by Elena Iemma | Mar 29, 2024 | Featured, News
PROVIDENCE, RI, April 1, 2024 /PRNewswire/ — In the pursuit of developing novel biologic entities, scientists harnessing the power of AI and generative biology depend on computational tools for predicting and managing immunogenicity risk – a critical...
by Annie De Groot | Nov 6, 2018 | Events
2nd International Conference on Therapeutic Antibodies in Mexico Thursday, November 29th and Friday, November 30th Hotel Hilton Reforma, CDMX We had a great time at this event! Check out photos from the seminar below. Annie De Groot – CEO/CSO, EpiVax Rob Etches...
by Annie De Groot | Nov 26, 2013 | News
Beyond humanization and de-immunization: tolerization as a method for reducing the immunogenicity of biologics Expert Rev. Clin. Pharmacol. 6(6), 651–662 (2013) Abstract Immune responses to some monoclonal antibodies (mAbs) and biologic proteins interfere with their...